Segment Information (Tables)

3 Months Ended

Sep. 30, 2022

Segment Reporting, Revenue Reconciling Item [Line Items]

Revenue from External Customers by Geographic Areas [Table Text Block]

The following table presents revenue by geographic area:

	Three Months Ended September 30,
(in millions)	2022		2021
United States	$	48,477	$	42,841
International	1,129		1,130
Total segment revenue	49,606		43,971
Corporate (1)	(3)		(3)
Total revenue	$	49,603	$	43,968

(1)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.

Schedule of Segment Reporting Information, by Segment [Table Text Block]

Revenue

The following table presents revenue for each reportable segment, disaggregated revenue within our two reportable segments and Corporate:

	Three Months Ended September 30,
(in millions)	2022		2021
Pharmaceutical Distribution and Specialty Solutions (1) (2)	$	45,547	$	39,614
Nuclear and Precision Health Solutions (3)	281		208
Pharmaceutical segment revenue	45,828		39,822
Medical distribution and products (4)	3,140		3,567
Cardinal Health at-Home Solutions	638		582
Medical segment revenue	3,778		4,149
Total segment revenue	49,606		43,971
Corporate (5)	(3)		(3)
Total revenue	$	49,603	$	43,968

(1)Products and services offered by our Specialty Solutions division are referred to as “specialty pharmaceutical products and services".

(2)Comprised of all Pharmaceutical segment businesses except for Nuclear and Precision Health Solutions division.

(3)Increase from prior year primarily relates to new product launches and, to a lesser extent, the impact of a change in revenue recognition presentation from agent to principal for certain customer contracts.

(4)Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division.

(5)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments

Segment Profit by Reportable Segment

The following table presents segment profit by reportable segment and Corporate:

	Three Months Ended September 30,
(in millions)	2022		2021
Pharmaceutical	$	431	$	406
Medical	(8)		123
Total segment profit	423		529
Corporate	(286)		(114)
Total operating earnings	$	137	$	415

Assets by Reportable Segment

The following table presents total assets for each reportable segment and Corporate at:

(in millions)	September 30, 2022		June 30, 2022
Pharmaceutical	$	27,253	$	26,409
Medical	11,338		11,632
Corporate	4,796		5,837
Total assets	$	43,387	$	43,878